| UniProt ID | RABE2_HUMAN | |
|---|---|---|
| UniProt AC | Q9H5N1 | |
| Protein Name | Rab GTPase-binding effector protein 2 | |
| Gene Name | RABEP2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 569 | |
| Subcellular Localization | Cytoplasm . Early endosome . | |
| Protein Description | Plays a role in membrane trafficking and in homotypic early endosome fusion.. | |
| Protein Sequence | MAAAAPVAADDDERRRRPGAALEDSRSQEGANGEAESGELSRLRAELAGALAEMETMKAVAEVSESTKAEAVAAVQRQCQEEVASLQAILKDSISSYEAQITALKQERQQQQQDCEEKERELGRLKQLLSRAYPLDSLEKQMEKAHEDSEKLREIVLPMEKEIEELKAKLLRAEELIQEIQRRPRHAPSLHGSTELLPLSRDPSPPLEPLEELSGDGGPAAEAFAHNCDDSASISSFSLGGGVGSSSSLPQSRQGLSPEQEETASLVSTGTLVPEGIYLPPPGYQLVPDTQWEQLQTEGRQLQKDLESVSRERDELQEGLRRSNEDCAKQMQVLLAQVQNSEQLLRTLQGTVSQAQERVQLQMAELVTTHKCLHHEVKRLNEENQGLRAEQLPSSAPQGSQQEQGEEESLPSSVPELQQLLCCTRQEARARLQAQEHGAERLRIEIVTLREALEEETVARASLEGQLRVQREETEVLEASLCSLRTEMERVQQEQSKAQLPDLLSEQRAKVLRLQAELETSEQVQRDFVRLSQALQVRLERIRQAETLEQVRSIMDEAPLTDVRDIKDT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAAAPVAA ------CCCCCCCCC | 13.05 | 22814378 | |
| 25 | Phosphorylation | PGAALEDSRSQEGAN CCCCHHCCCCCCCCC | 25.18 | 24719451 | |
| 27 | Phosphorylation | AALEDSRSQEGANGE CCHHCCCCCCCCCCC | 36.21 | 21815630 | |
| 56 | Phosphorylation | GALAEMETMKAVAEV HHHHHHHHHHHHHHH | 23.74 | 22210691 | |
| 91 | Ubiquitination | ASLQAILKDSISSYE HHHHHHHHHHHHHHH | 43.23 | 29967540 | |
| 93 | Phosphorylation | LQAILKDSISSYEAQ HHHHHHHHHHHHHHH | 23.84 | 24719451 | |
| 105 (in isoform 2) | Ubiquitination | - | 47.88 | 21890473 | |
| 105 (in isoform 1) | Ubiquitination | - | 47.88 | 21890473 | |
| 105 | Ubiquitination | EAQITALKQERQQQQ HHHHHHHHHHHHHHH | 47.88 | 23000965 | |
| 126 | Acetylation | ERELGRLKQLLSRAY HHHHHHHHHHHHHHC | 37.22 | 12650579 | |
| 126 | Ubiquitination | ERELGRLKQLLSRAY HHHHHHHHHHHHHHC | 37.22 | 29967540 | |
| 161 | Ubiquitination | EIVLPMEKEIEELKA HHHHCCHHHHHHHHH | 58.71 | - | |
| 189 | Phosphorylation | RRPRHAPSLHGSTEL HCCCCCCCCCCCCCC | 33.51 | 23401153 | |
| 193 | Phosphorylation | HAPSLHGSTELLPLS CCCCCCCCCCCCCCC | 14.15 | 28176443 | |
| 194 | Phosphorylation | APSLHGSTELLPLSR CCCCCCCCCCCCCCC | 34.93 | 28176443 | |
| 200 | Phosphorylation | STELLPLSRDPSPPL CCCCCCCCCCCCCCC | 32.47 | 29255136 | |
| 204 | Phosphorylation | LPLSRDPSPPLEPLE CCCCCCCCCCCCCHH | 43.36 | 26074081 | |
| 214 | Phosphorylation | LEPLEELSGDGGPAA CCCHHHHCCCCCHHH | 37.81 | 28348404 | |
| 231 | Phosphorylation | FAHNCDDSASISSFS HHHCCCCCCCCCEEE | 15.63 | 28348404 | |
| 233 | Phosphorylation | HNCDDSASISSFSLG HCCCCCCCCCEEECC | 27.27 | 28348404 | |
| 235 | Phosphorylation | CDDSASISSFSLGGG CCCCCCCCEEECCCC | 23.88 | 28348404 | |
| 236 | Phosphorylation | DDSASISSFSLGGGV CCCCCCCEEECCCCC | 19.72 | 28348404 | |
| 238 | Phosphorylation | SASISSFSLGGGVGS CCCCCEEECCCCCCC | 28.22 | 28348404 | |
| 257 | Phosphorylation | PQSRQGLSPEQEETA CHHHCCCCHHHHHHH | 32.96 | 28348404 | |
| 263 | Phosphorylation | LSPEQEETASLVSTG CCHHHHHHHHHHCCC | 22.31 | 28348404 | |
| 265 | Phosphorylation | PEQEETASLVSTGTL HHHHHHHHHHCCCCC | 36.40 | 24275569 | |
| 268 | Phosphorylation | EETASLVSTGTLVPE HHHHHHHCCCCCCCC | 26.81 | 24275569 | |
| 271 | Phosphorylation | ASLVSTGTLVPEGIY HHHHCCCCCCCCCEE | 25.35 | 24275569 | |
| 400 | Phosphorylation | PSSAPQGSQQEQGEE CCCCCCCCCCCCCCC | 24.36 | 28348404 | |
| 409 | Phosphorylation | QEQGEEESLPSSVPE CCCCCCCCCCCCCHH | 49.19 | 28348404 | |
| 497 | Ubiquitination | RVQQEQSKAQLPDLL HHHHHHHHHCCCHHH | 39.59 | 24816145 | |
| 532 | Phosphorylation | QRDFVRLSQALQVRL HHHHHHHHHHHHHHH | 11.66 | 22210691 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RABE2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RABE2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| BRCC3_HUMAN | BRCC3 | physical | 22863883 | |
| LARP7_HUMAN | LARP7 | physical | 22863883 | |
| NOLC1_HUMAN | NOLC1 | physical | 22863883 | |
| RPB2_HUMAN | POLR2B | physical | 22863883 | |
| RPAB1_HUMAN | POLR2E | physical | 22863883 | |
| WDHD1_HUMAN | WDHD1 | physical | 22863883 | |
| EXOC1_HUMAN | EXOC1 | physical | 27173435 | |
| EXOC4_HUMAN | EXOC4 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |